Mentions:
1: Mochan, Carol (Lab - South Scotland) Health visitor services are key to that. - Speech Link
2: Cole-Hamilton, Alex (LD - Edinburgh Western) We also know that it has a role to play in protecting mothers from ovarian cancer and breast cancer. - Speech Link
3: Harper, Emma (SNP - South Scotland) We have strong evidence that it reduces the risk of breast and ovarian cancer, and it is worth repeating - Speech Link
4: Marra, Michael (Lab - North East Scotland) and ovarian cancer for the mother. - Speech Link
5: Mackay, Rona (SNP - Strathkelvin and Bearsden) and ovarian cancer and some evidence that it may promote a healthy weight and reduce the risk of type - Speech Link
Asked by: Rachael Maskell (Labour (Co-op) - York Central)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, if she will make a comparative assessment of the adequacy of funding her Department provides to help tackle (a) less survivable cancers compared to (b) other cancers; and if she will make it her policy to (i) create a framework assessing the challenges around cancers with lower survival rates and (ii) increase funding for those cancers.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
The Government is taking steps through NHS England to improve outcomes for cancer patients, including those with less survivable cancers. Making improvements across different cancer types is critical to helping achieve the NHS Long Term Plan ambition of diagnosing 75% of patients at an early stage by 2028 and reducing inequalities in cancer survival. NHS England has commissioned new cancer clinical audits covering five cancer types, some of which are less survivable: pancreatic cancer, ovarian cancer, non-Hodgkin lymphoma, kidney cancer and primary and metastatic breast cancer. All five audits will cover care delivered in England and Wales and will see an investment of approximately £5.4 million for an initial period of three years.
NHS England is responsible for funding allocations to integrated care boards (ICBs). ICBs then decide how that money is spent within the local integrated care system. The allocations process is independent of Government and NHS England takes advice on the underlying formula from the independent Advisory Committee on Resource Allocation. NHS England produces a target allocation, or 'fair share' for each area, based on a complex assessment of factors such as demography, morbidity, deprivation, and the unavoidable cost of providing services in different areas. This means that funding decisions are fair and equitable.
Delivering more research is key to understanding and assessing the challenges around cancers with lower survival rates. As with other Government funders of health research, the National Institute for Health and Care Research (NIHR) does not allocate funding for specific disease areas, including less survivable cancers. The level of research spend in a particular area is driven by factors including scientific potential and the number and scale of successful funding applications. The NIHR welcomes funding applications for research into any aspect of human health, including less survivable cancers.
Mentions:
1: Yousaf, Humza (SNP - Glasgow Pollok) The early evaluation from those rapid cancer diagnostic services shows that hepato-pancreato-biliary - Speech Link
2: Baillie, Jackie (Lab - Dumbarton) According to Target Ovarian Cancer, people in the west of Scotland cannot access the life-saving surgery - Speech Link
3: Yousaf, Humza (SNP - Glasgow Pollok) Notwithstanding that, I want to see the work that we are doing, particularly on ovarian cancer, being - Speech Link
4: Mochan, Carol (Lab - South Scotland) Given all of that, what additional investment has been made in sexual health services to ensure that - Speech Link
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 31 October 2022Found: Rockville, MD:US Dept of Health and Human Services, Food and Drug Administration ;May 2003.
Jan. 17 2024
Source Page: Freedom of Information responses from the MHRA - week commencing 22 August 2022Found: and Nutrition Examination Survey NHS National Health Service NICE National Institute for Health and
Jan. 12 2024
Source Page: Official statistics: forthcoming publicationsFound: Quality Performance Indicators, February 2024Health and Care (PHS)27-Feb-2409:30National reporting of Ovarian
Oral Evidence Jan. 09 2024
Inquiry: Future cancerFound: health services, the funding tends to be quite evenly distributed between the tumours; it is the geographical
Jan. 09 2024
Source Page: Letter dated 27/12/2023 from Lord Markham to Baroness Hayter and other peers regarding the General Medical Council's internal guidance for pregnant and menopausal women. 2p.Found: also very important that trans men feel able to access and attend cervical screening or maternity services
Scrutiny evidence Jan. 08 2024
Committee: Scottish Affairs Committee (Department: Scotland Office)Found: Research UK Cancer Research UK Scotland Centre Established in 2022, the Cancer Research UK Scotland
Asked by: Andrew Rosindell (Conservative - Romford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve the diagnosis (a) rates and (b) treatments for ovarian cancer in (i) England and (ii) Romford constituency.
Answered by Andrew Stephenson - Minister of State (Department of Health and Social Care)
Improving the diagnosis rate and treatment for all cancers including for ovarian cancer, is a priority for this Government. The Department is working with NHS England and is taking steps across England to increase diagnosis rates, including setting stretching ambitions, supporting general practitioners (GPs) in referring patients, expanding diagnostic capacity and enabling more precise diagnosis through technology. These steps and actions apply in Romford as across England.
To encourage people to see their general practitioner if they notice symptoms that could be cancer, NHS England runs the ‘Help Us, Help You’ campaigns, which address the barriers that deter patients from accessing the National Health Service. NHS England is currently running a ‘Help us Help you’ campaign highlighting the abdominal and urological symptoms of cancer, including ovarian cancer, and addressing the barriers that stop people from accessing services in the NHS.
NHS England introduced the Faster Diagnosis Standard (FDS) which aims to ensure patients have cancer diagnosed or ruled out within 28 days of urgent referral from a GP or screening services with a 75% standard ambition. To achieve the FDS, NHS England has implemented ‘non-specific symptom pathways’ for patients who have symptoms that do not align to a particular type of tumour, including for non-specific symptoms of pancreatic cancer.
Further to this, the Department has committed to £2.3 billion of capital funding to expanding diagnostic capacity across the NHS by rolling out more community diagnostic centres, delivering vital tests, scans and checks, including for ovarian cancer.
The Department invests in health research through the National Institute for Health and Care Research (NIHR). NIHR has funded six research projects into screening for ovarian cancer since 2018, with a combined total funding value of £3.8 million, including looking at the impact and effectiveness of different kinds of testing and screening and effectiveness of treatment options. The overall goal is to improve diagnosis and treatment to improve patient outcomes.